Facilitated By

San Antonio Medical Foundation

AT-100 in vivo efficacy against SARS-CoV-2

Texas Biomedical Research Institute

 

As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Torrelles, Jordi B
Funded by
Airway Therapeutics
Research Start Date
Status
Active

The goal is to determine the effectivity of AT-100 post-infection in blocking SARS-CoV-2 infectivity.

Collaborative Project
Drug Discovery
Infectious Disease